Pharma

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.

Patients can see the discounted prices on TrumpRx.gov, but the site does not currently sell the drugs.

AION Labs CEO, Mati Gill, discusses the company’s extensive backing from pharma and tech giants to build AI startups, and how AION is looking beyond AI to explore quantum technologies for research and development in drug discovery.

AION Labs CEO sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss the acquisition he says represents a milestone for Israel’s biotech ecosystem.

Outside the JPM Healthcare Conference, Thomas Clozel, cofounder and CEO of Owkin, sat down with MobiHealthNews to discuss how the company is using AI to find causality in disease.

The San Francisco-based lab will house Eli Lilly experts in biology, science and medicine alongside NVIDIA AI model builders and engineers.

Pharma faces regulations and stringent rules for transparency, but the payoff is drugs that can get to market faster and possibly at less expense.

uMed’s registry platform will work alongside WellSky’s network of home-based care organizations to let patients participate in national clinical trials from home.

During a fireside chat with Scripta Insights’ CEO, Cuban discussed TrumpRx and unveiled new MCCPDC innovations, including mobile drug-making pods and the Cost Plus Wellness network.

The partnership will expedite the availability of Freenome's tests in markets outside the U.S, according to the company.